In the EF-14 phase III trial, TTFields (200 kHz) plus temozolomide (TMZ) significantly increased the survival of patients with newly diagnosed GBM (ndGBM) without increase in systemic toxicity.

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...

This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...

Brooks Jr. states in the lawsuit that he "passed out" during practice, and "then began to vomit minutes later in front of his ...

PHILADELPHIA, PA — Imvax, Inc, recently closed a $29 million financing round from existing investors. This marks the latest ...

Former LSU football player Greg Brooks Jr. has filed a lawsuit against the university, alleging medical negligence. Here's ...

Brain cancer is the second-leading cause of death in children in the developed world. For the children who survive, standard ...

AN INSPIRATIONAL mum who was told more than three years ago that she would not see her daughter’s first birthday has shared an update on ...

Published recently in the journal Frontiers in Nutrition, the report is the first evaluation of the use of ketogenic metabolic therapy (KMT) without chemo or radiation interventions, on a patient ...

LAUREL CO., Ky. (LEX 18) — A Laurel County nine-year-old has been diagnosed with a highly aggressive cancerous brain tumor.

An Ohio mom diagnosed with cancer is opening up after police officers in her community surprised her by shaving their heads ...

Radiotherapy is an important part of glioblastoma (GBM) treatment, but patient outcomes are often limited by resistance. Here, the authors identify a role for IFI16 in the promotion of a cellular ...